Supply Chain News
NIPPON EXPRESS HOLDINGS establishes “NX Group Sustainable Procurement Policy”
December 20, 2023
NIPPON EXPRESS HOLDINGS, INC. (President: Mitsuru Saito), recently formulated a sustainable procurement policy applicable across the entire NX Group. The NX Group embodies a corporate philosophy of being a driving force for social development, creating new ideas and value that expand the field of logistics, Full Article
Top Transportation Technology Trends
December 6, 2023
This is the time of year when industry analysts and technology pundits make predictions about the future. McKinsey & Company, a worldwide management consulting firm, has done the same. However, their predictions are based, in part, on a survey of more than 250 global shippers Full Article
NIPPON EXPRESS HOLDINGS signs strategic partnership with US-based Cryoport
November 30, 2023
-Collaboration aimed at providing cryogenic transport services globally- NIPPON EXPRESS HOLDINGS, INC. (President: Mitsuru Saito), has entered into a strategic partnership with Cryoport Systems (President: Jerrell W. Shelton; hereinafter "Cryoport"), a group company of the US-based specialized pharmaceutical carrier Cryoport, Inc., to provide the global Full Article
Process Improvement: Achieving a More Efficient Life Sciences and Pharmaceutical Warehouse
November 27, 2023
Background Improving efficiencies within the supply chain is a continuous improvement with ongoing initiatives. As such, logistics providers are always measuring and analyzing processes to uncover ways to increase efficiencies within the warehouse. The Life Sciences and Pharmaceuticals industries have witnessed tremendous growth in recent years Full Article
Tackling the Impending DSCSA Readiness Hurdles with a More Integrated Tech Approach
November 16, 2023
Although the U.S. Food and Drug Administration (FDA)’s Drug Supply Chain Security Act (DSCSA) recently granted a reprieve for one year before sanctioning pharmaceutical companies, the November 27, 2023, deadline nevertheless remains. Ten years in the making, the last DSCSA phase requires stakeholders in pharmaceutical Full Article
